Skin metastases in breast cancer
Pro Research Analysisby 
Searched over 200M research papers
Incidence and Prognosis of Skin Metastases in Breast Cancer
Skin metastases are a recognized but relatively uncommon complication of breast cancer, occurring in approximately 0.6% to 10.4% of cases, and are more frequent in women than in men. They often indicate advanced disease and are associated with a poor prognosis, as their presence usually signifies widespread systemic involvement Rehman2020Grecia2024Șandru2020+2 MORE. In women, breast cancer is the most common source of cutaneous metastases, accounting for up to 70% of such cases .
Clinical Presentation and Morphological Diversity
The clinical appearance of skin metastases from breast cancer is highly variable. The most common presentation is the development of firm, painless nodules on the chest wall, abdomen, or upper extremities, but other forms include erythematous plaques, ulcerated lesions, and diffuse skin thickening Rehman2020Grecia2024Cohen2021+3 MORE. Classic patterns include carcinoma erysipelatoides, carcinoma telangiectoides, and carcinoma en cuirasse, but unusual morphologies such as pigmented plaques, targetoid lesions, and even clown-nose-like infiltrations have been reported Cohen2021Morisaka2021. These lesions can mimic benign skin conditions, infections, or other malignancies, making diagnosis challenging Rehman2020Cohen2021Grecia2024.
Diagnostic Challenges and Tools
Because of their diverse appearance, skin metastases can be mistaken for benign or unrelated skin conditions. Dermatoscopy can help differentiate metastatic lesions from other skin diseases by revealing features such as polymorphic vessels and chrysalis-like structures, but histological confirmation via biopsy remains essential for diagnosis Rehman2020Vashkevich2022Cohen2021. Imaging studies like mammography, ultrasound, CT, and MRI can assist in evaluating the extent of disease, especially in cases of recurrence after mastectomy or breast-conserving therapy .
Molecular and Pathological Features
Cutaneous metastases from breast cancer may differ molecularly from the primary tumor and from metastases in other organs. Identifying molecular markers that predict the risk of skin metastasis is an area of ongoing research, with the goal of improving targeted therapies and patient outcomes .
Treatment Approaches
Management of skin metastases in breast cancer typically involves systemic therapies such as chemotherapy, endocrine therapy, and immunotherapy, as well as local treatments like surgery and radiotherapy Șandru2020Ferioli2020. Electrochemotherapy (ECT) has emerged as a promising local treatment, showing good response rates, especially in smaller lesions, and manageable side effects . Surgery is often palliative, aimed at preventing complications like ulceration or infection, rather than curative .
Importance of Early Recognition
Early identification of skin metastases is crucial for timely intervention and can sometimes be the first sign of cancer recurrence or progression Rehman2020Grecia2024Vashkevich2022+1 MORE. Awareness of the wide range of clinical presentations is essential for healthcare providers to avoid misdiagnosis and to initiate appropriate management promptly Rehman2020Grecia2024Cohen2021+1 MORE.
Conclusion
Skin metastases in breast cancer are a sign of advanced disease and present with a wide variety of clinical appearances, often mimicking benign conditions. Accurate diagnosis relies on clinical suspicion, dermatoscopic evaluation, imaging, and histological confirmation. Treatment is challenging and often palliative, but new approaches like electrochemotherapy offer hope for improved local control. Early recognition and diagnosis are key to optimizing patient care and outcomes.
Sources and full results
Most relevant research papers on this topic